TP53 and endometrial endometrioid carcinoma: Our review corroborates and strengthens the findings of the existing body of literature that abnormal p53 G3 endometrioid endometrial carcinomas have a poor prognosis with an increased risk of recurrence and decreased OS [5,6,12,31].